ANI Pharmaceuticals ANIP Stock
ANI Pharmaceuticals Price Chart
ANI Pharmaceuticals ANIP Financial and Trading Overview
ANI Pharmaceuticals stock price | 68.29 USD |
Previous Close | 49.67 USD |
Open | 49.5 USD |
Bid | 0 USD x 1000 |
Ask | 0 USD x 900 |
Day's Range | 49.47 - 51.25 USD |
52 Week Range | 23.09 - 52.23 USD |
Volume | 131.37K USD |
Avg. Volume | 109.25K USD |
Market Cap | 1.02B USD |
Beta (5Y Monthly) | 1.027464 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.04 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 52.4 USD |
ANIP Valuation Measures
Enterprise Value | 1.08B USD |
Trailing P/E | N/A |
Forward P/E | 11.793022 |
PEG Ratio (5 yr expected) | 6.9 |
Price/Sales (ttm) | 2.8482192 |
Price/Book (mrq) | 2.6726043 |
Enterprise Value/Revenue | 3.019 |
Enterprise Value/EBITDA | 16.79 |
Trading Information
ANI Pharmaceuticals Stock Price History
Beta (5Y Monthly) | 1.027464 |
52-Week Change | 107.99% |
S&P500 52-Week Change | 20.43% |
52 Week High | 52.23 USD |
52 Week Low | 23.09 USD |
50-Day Moving Average | 42.91 USD |
200-Day Moving Average | 40.02 USD |
ANIP Share Statistics
Avg. Volume (3 month) | 109.25K USD |
Avg. Daily Volume (10-Days) | 109.82K USD |
Shares Outstanding | 20.15M |
Float | 12.29M |
Short Ratio | 1.43 |
% Held by Insiders | 13.51% |
% Held by Institutions | 73.43% |
Shares Short | 255.62K |
Short % of Float | 1.92% |
Short % of Shares Outstanding | 1.27% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -7.34% |
Operating Margin (ttm) | 1.30% |
Gross Margin | 60.35% |
EBITDA Margin | 17.97% |
Management Effectiveness
Return on Assets (ttm) | 0.38% |
Return on Equity (ttm) | -7.67% |
Income Statement
Revenue (ttm) | 358.69M USD |
Revenue Per Share (ttm) | 21.97 USD |
Quarterly Revenue Growth (yoy) | 65.60% |
Gross Profit (ttm) | 177.6M USD |
EBITDA | 64.49M USD |
Net Income Avi to Common (ttm) | -28066000 USD |
Diluted EPS (ttm) | -1.75 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 67.76M USD |
Total Cash Per Share (mrq) | 4.09 USD |
Total Debt (mrq) | 286.31M USD |
Total Debt/Equity (mrq) | 84.34 USD |
Current Ratio (mrq) | 2.899 |
Book Value Per Share (mrq) | 18.974 |
Cash Flow Statement
Operating Cash Flow (ttm) | 9.16M USD |
Levered Free Cash Flow (ttm) | 15.99M USD |
Profile of ANI Pharmaceuticals
Country | United States |
State | MN |
City | Baudette |
Address | 210 Main Street West |
ZIP | 56623 |
Phone | 218 634 3500 |
Website | https://www.anipharmaceuticals.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 600 |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Q&A For ANI Pharmaceuticals Stock
What is a current ANIP stock price?
ANI Pharmaceuticals ANIP stock price today per share is 68.29 USD.
How to purchase ANI Pharmaceuticals stock?
You can buy ANIP shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ANI Pharmaceuticals?
The stock symbol or ticker of ANI Pharmaceuticals is ANIP.
Which industry does the ANI Pharmaceuticals company belong to?
The ANI Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does ANI Pharmaceuticals have in circulation?
The max supply of ANI Pharmaceuticals shares is 21.76M.
What is ANI Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
ANI Pharmaceuticals PE Ratio is now.
What was ANI Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
ANI Pharmaceuticals EPS is -1.04 USD over the trailing 12 months.
Which sector does the ANI Pharmaceuticals company belong to?
The ANI Pharmaceuticals sector is Healthcare.
ANI Pharmaceuticals ANIP included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
NASDAQ Biotechnology Total Retu XNBI | 4469.42 USD — |
-1.87
|
— — | 4461.55 USD — | 4528.54 USD — | — - | — — |
NASDAQ Global Market Composite NQGM | 1737.75 USD — |
-6
|
— — | 1724.84 USD — | 1770.8 USD — | — - | — — |
NASDAQ Biotechnology NBI | 4130.78 USD — |
-1.87
|
— — | 4123.5 USD — | 4185.42 USD — | — - | — — |
NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
NASDAQ Composite Total Return I XCMP | 20257.83 USD — |
-5.96
|
— — | 20236.33 USD — | 20672.41 USD — | — - | — — |
Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}